Cargando…
Sudden cardiac death due to β(2)-agonist therapy: is a genetic basis overlooked?
Autores principales: | Yalta, K, Sivri, N, Geyik, B, Aksoy, Y, Yetkin, E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Clinics Cardive Publishing
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3721299/ https://www.ncbi.nlm.nih.gov/pubmed/22447478 |
Ejemplares similares
-
Recurrent Cardiac Myxoma: A Puzzle to be Solved
por: Yalta, Kenan, et al.
Publicado: (2023) -
Systemic Inflammation in the Setting of Cardiac Myxomas: an Overview of Clinical and Practical Considerations
por: Yalta, Kenan, et al.
Publicado: (2021) -
Cardiac Sarcoidosis: Indications for Implantable Cardioverter-Defibrillator Therapy
por: Yalta, Kenan, et al.
Publicado: (2022) -
Potential causes of sudden cardiac death in nemaline myopathy
por: Finsterer, Josef, et al.
Publicado: (2015) -
Sudden cardiac death in physicians: an alarming problem in China
por: Shi, Xinmiao, et al.
Publicado: (2018)